O Positiv Health has introduced a deeply hydrating vaginal suppository product, simply referred to as the URO Vaginal Moisture Suppository. This product uses a hormone-free insert containing hyaluronic acid and nourishing triglycerides to support vaginal hydration, daily comfort, and revitalized intimacy.
O Positiv Health's URO Vaginal Moisture Suppository is sure to capture consumer attention as statistics show that nearly half of U.S. women experience vaginal dryness due to hormone changes, stress, medications, diet, or aging, yet many endure discomfort silently or rely on temporary lubricants that do not address the underlying tissue condition. The URO Vaginal Moisture Suppository delivers a clinically studied five-milligram dose of hyaluronic acid directly to the vaginal lining, where it naturally attracts and retains moisture, which helps the tissue become softer, smoother, and more elastic over time. The addition of triglycerides provides immediate cushion and comfort upon contact.
Image Credit: O Positiv Health
Why This Trend Is Growing
- Localized Biologic Delivery
- Direct mucosal delivery of small-dose biologics could redefine targeted tissue regeneration and reduce systemic exposure.
- Hyaluronic Acid Feminine Care
- An expansion of hyaluronic acid formulations tailored for mucosal resilience could shift consumer preference from temporary lubricants to restorative treatments.
- Hormone-free Intimate Therapeutics
- Non-hormonal modalities that restore tissue function may create options for populations contraindicated for systemic hormone therapies.
Industries Being Reshaped
- Sexual Wellness Products
- This market could experience category convergence as therapeutic suppositories are positioned alongside lifestyle intimacy offerings.
- Pharmaceuticals for Women
- Regulatory-grade, locally delivered hyaluronic therapies may lead to distinct prescription and over-the-counter segments focused on long-term vaginal health.
- Medical Device-adjacent Drug Delivery
- Solid insert technologies combining excipients and actives for sustained mucosal hydration have the potential to blur the boundary between devices and drugs.
